Renal Cancer
A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma - Abstract
April 5, 2011
Treatment-associated adverse event management in the advanced renal cell carcinoma patient treated with targeted therapies - Abstract
March 30, 2011
Targeted therapies for the treatment of metastatic renal cell carcinoma: Clinical evidence - Abstract
March 29, 2011
Retrospective analyses of patient characteristics having predictive impact on survival under everolimus - Abstract
March 25, 2011